Tissue Heart Valves Market to Grow at a CAGR of 2.6% from 2025 to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Tissue Heart Valves Market Size During 2025–2029?

The overall valuation for the tissue heart valves sector has witnessed consistent upward movement over the preceding years. Projections indicate an expansion from its current worth of $1.48 billion in the year 2024 to an estimated $1.52 billion by 2025, reflecting a compound annual growth rate of 2.3%. This past period’s expansion trajectory is fundamentally linked to several key factors: the increasingly widespread nature of lifestyle-related illnesses, escalating public spending on healthcare solutions, the demographic shift toward an aging population, a higher incidence of both cardiovascular and general pathological conditions, and the surging frequency of heart-related ailments.

Anticipating a consistent upward trajectory, the overall valuation of the tissue heart valves sector is projected to reach $1.68 billion by the year 2029, expanding at a consistent compound annual growth rate (CAGR) of 2.6% over the coming period. This materializing growth is fundamentally underpinned by several key factors: a heightened incidence of ailments affecting the heart and blood vessels, the escalating preference for surgical methods that forgo sutures, the demographic shift towards an older global populace, a perpetually strengthening need for effective treatments addressing cardiac conditions, and augmented fiscal commitments within the healthcare domain. Furthermore, this future growth phase will be significantly shaped by dominant market currents such as continuous breakthroughs in technology, the adoption of novel cell culturing methodologies, improvements in diagnostic visualization tools, progressive developments in operative procedures, and market penetration into developing economies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21302&type=smp

Which Factors And Drivers Are Influencing The Tissue Heart Valves Market In 2025?

Anticipated expansion in the incidence of heart and blood vessel disorders is set to fuel the tissue heart valves sector’s advancement in the near future. A collection of ailments impacting the cardiac system and vasculature, encompassing instances like strokes, myocardial infarctions, and elevated blood pressure, constitutes cardiovascular diseases (CVDs). The surging occurrences of CVDs are majorly instigated by elements such as sedentary habits, the aging demographic structure, a greater incidence of associated hazards, substandard dietary patterns, insufficient physical movement, tobacco use, elevated stress levels, and intensified urbanization, all contributing to a worldwide escalation in heart-related pathologies. These tissue heart valves serve a vital role in managing CVDs by offering a replacement option that is durable, compatible with the body, and less prone to clot formation for individuals needing valve substitution, thereby enhancing sustained cardiac performance and mitigating the likelihood of adverse outcomes. To illustrate this escalating need, data released in September 2024 by the Heart Failure Society of America (HFSA), a professional US entity, revealed that about 6.7 million US adults aged 20 and above currently manage heart failure (HF), with forecasts suggesting this figure will climb to 8.7 million by 2030, further growing to 10.3 million by 2040, and reaching 11.4 million by 2050. Consequently, the rising tide of cardiovascular illnesses is acting as a significant impetus for the growth trajectory within the tissue heart valve market.

What Are The Segment Types Shaping The Tissue Heart Valves Market?

The tissue heart valvesmarket covered in this report is segmented –

1) By Type: Stented Tissue Heart Valves, Stentless Tissue Heart Valves

2) By Valve Type: Aortic, Mitral, Tricuspid, Pulmonary

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Stented Tissue Heart Valves: Bovine Pericardial Valves, Porcine Valves

2) By Stentless Tissue Heart Valves: Bovine Pericardial Stentless Valves, Homograft Valves

Which Competitive Trends Are Defining The Tissue Heart Valves Market Structure?

Key players within the realm of tissue heart valves are concentrating their efforts on pioneering novel solutions, specifically surgical aortic tissue valves, aiming to simplify both the implantation process and ongoing patient care throughout the device’s lifespan. This type of prosthetic heart valve, constructed from organic tissue, serves as a substitute for a compromised or unhealthy aortic valve during cardiac operations. As an illustration, in June of 2024, the Ireland-headquartered technology firm, Medtronic plc., introduced the Avalus Ultra valve, representing an advanced iteration of a surgical aortic tissue valve engineered to streamline handling during placement and aid in sustained patient follow-up. This new device benefits from a decade of clinical data accumulated from its predecessor, the Avalus valve, incorporating features such as a reduced valve height, a frame composed of polyetheretherketone (PEEK) to ensure consistent roundness, and an industry-best Effective Orifice Area (EOA) designed to promote superior blood circulation, further bolstered by a radiopaque coil that ensures clear imaging for subsequent valve-in-valve interventions, thus providing lasting reliability for individuals suffering from aortic stenosis.

Who Are The Core Companies Influencing The Tissue Heart Valves Market Landscape?

Major companies operating in the tissue heart valves market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, LifeNet Health Inc., TTK Healthcare Ltd., Braile Biomédica, On-X Life Technologies Inc., Anteris Technologies Ltd., Labcor Laboratórios Ltd., CARDION s.r.o., CryoLife Inc., Colibri Heart Valve LLC, Foldax Inc., Balance Medical Technologies Co. Ltd., MiCardia Corporation, Neovasc Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/tissue-heart-valves-global-market-report

Which Geographies Are Emerging As Strong Markets For The Tissue Heart Valves Industry?

North America was the largest region in the tissue heart valves market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tissue heart valves market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Tissue Heart Valves Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21302&type=smp

Browse Through More Reports Similar to the Global Tissue Heart Valves Market 2025, By The Business Research Company

Prosthetic Heart Valve Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/prosthetic-heart-valve-devices-and-equipment-global-market-report

Hearth Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hearth-global-market-report

Flea Tick And Heartworm Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/flea-tick-and-heartworm-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795